-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2010 to Q2 2024.
- Elite Pharmaceuticals Inc /Nv/ Net Cash Provided by (Used in) Financing Activities for the quarter ending June 30, 2024 was -$175K, a 104% decline year-over-year.
- Elite Pharmaceuticals Inc /Nv/ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.39M, a 98.9% increase from 2022.
- Elite Pharmaceuticals Inc /Nv/ annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.7M.
- Elite Pharmaceuticals Inc /Nv/ annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$667K, a 23.3% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)